NCT05852405View on ClinicalTrials.gov

Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS

CompletedOBSERVATIONAL

Enrollment

2,000

Participants

Timeline

Start Date

August 1, 2021

Primary Completion Date

December 31, 2024

Study Completion Date

December 31, 2024

Conditions

Motor Neuron Disease, Amyotrophic Lateral Sclerosis

Trial Locations (1)

13353

Center for ALS and other motor neuron disorders, Charité - Universitätsmedizin Berlin, Berlin

All Listed Sponsors

collaborator

Charite University, Berlin, Germany

OTHER

lead

Ambulanzpartner Soziotechnologie APST GmbH

INDUSTRY

NCT05852405 - Clinical Characteristics, Natural History, Health Care Measures, and Genetic Screening in Patients With ALS | Biotech Hunter | Biotech Hunter